科赛特制药宣布,公司已成功从Assertio Holdings, Inc.收购其旗下产品Sympazan®以及若干附加药品。此次收购将显著扩充科赛特制药的品牌产品线,进一步强化其在医药市场的竞争力与产品多样性。
科赛特制药宣布,公司已成功从Assertio Holdings, Inc.收购其旗下产品Sympazan®以及若干附加药品。此次收购将显著扩充科赛特制药的品牌产品线,进一步强化其在医药市场的竞争力与产品多样性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.